YSYang Shao

Yang Shao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yang Shao has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synovial inflammation and immune-stromal crosstalk in osteoarthritis-related synovial fibroblast research, 2006–2025: a bibliometric analysis

    by Tiange Xia, Xiaoyan Sun, Zhiwei Jiang, Yijie Zhang, Yi Zhou, Yang Shao, Shaoshuo Li, Jianwei Wang

    Background: Osteoarthritis (OA) is increasingly understood as a whole-joint organ disease involving cartilage, synovium, subchondral bone, and the local immune-stromal microenvironment. Synovial fibroblasts and fibroblast-like synoviocytes (FLS) participate in synovitis, matrix remodeling, cartilage-synovium crosstalk, pain-associated microenvironments, and disease heterogeneity. However, the knowledge structure, main knowledge sources, and frontier evolution of OA-related synovial fibroblast research remain incompletely mapped. Methods: We retrieved publications on OA-related synovial fibroblasts/fibroblast-like synoviocytes (OA-FLS) published from 2006 to 2025 from the Web of Science Core Collection (WOSCC) and Scopus. After integration and deduplication, Bibliometrix, CiteSpace, VOSviewer, and Python were used to analyze annual publication trends, national and institutional contributions, author and journal distributions, collaboration networks, global and local citation structures, keyword co-occurrence, trend topics, and thematic evolution. Results: A total of 1,881 publications were included, comprising 1,642 articles and 239 reviews. Annual output increased from 53 publications in 2006 to 142 in 2025, with an annual growth rate of 5.32%. China contributed the largest number of publications, whereas international collaboration remained relatively limited. Keyword and citation structures indicated a strong influence of RA-FLS-related knowledge sources. Recent hotspots increasingly involved synovitis, immune-stromal interaction, extracellular vesicle-mediated communication, fibrosis, pain-associated fibroblast states, and single-cell/spatially related studies. Conclusion: OA-FLS research has expanded from early studies of inflammatory mediators and catabolic pathways toward questions about fibroblast states, tissue location, immune-stromal interaction, and clinical phenotype association. These findings suggest a gradual movement from RA-derived conceptual borrowing toward more OA-contextualized interpretation, although this pattern should be understood as a bibliometric inference rather than direct mechanistic proof. Future studies need to clarify which OA-FLS states have stable, reproducible, and pathologically meaningful disease associations through standardized sampling, multicenter validation, spatial localization, functional experiments, and integration with clinical phenotypes.

  • Matrix Competence Failure in Osteoporosis: Mechanosensing, Osteoimmune Crosstalk, and Fragility Beyond Bone Mineral Density

    by Tian-Ge Xia, Yi-Jie Zhang, Shao-Shuo Li, Yi Zhou, Wen-Yu Tian, Zhi-Wei Jiang, Yang Shao, Jian-Wei Wang


  • Open Access

    Comparison of three large language models in postoperative rehabilitation question answering after anterior cruciate ligament reconstruction based on expert ratings

    by Tiange Xia, Yijie Zhang, Shaoshuo Li, Yi Zhou, Wenyu Tian, Zhiwei Jiang, Yang Shao, Jianwei Wang

    Large language models (LLMs) are increasingly used by patients to obtain health information. Postoperative rehabilitation after anterior cruciate ligament reconstruction (ACLR) has distinct phase boundaries and safety considerations. Therefore, responses should be not only clear and understandable, but also medically accurate, safe, and stage-fit. This study compared the performance of three publicly accessible LLMs in standardized post-ACLR rehabilitation question answering. This was a standardized, blinded, expert-rated comparative evaluation study. On a single prespecified data collection day in March 2026, 30 English-language rehabilitation questions were submitted separately to GPT-5.4, Doubao, and MiniMax-M2.7. The questions covered five postoperative rehabilitation phases. Responses were anonymized and randomly reordered before blinded rating by five orthopaedic clinicians across five domains: Accuracy, Safety, Stage-fit, Completeness, and Understandability. Paired non-parametric tests, effect size analyses, intraclass correlation coefficients, and linear mixed-effects modelling were used for statistical analysis. A total of 90 model-generated responses and 450 expert rating records were included. Overall scores differed significantly among the three models (Friedman χ² = 46.067, P < 0.001; Kendall's W = 0.768). GPT-5.4 achieved the highest overall score (4.61 ± 0.13), followed by MiniMax-M2.7 (4.53 ± 0.19), whereas Doubao had the lowest score (3.86 ± 0.29). GPT-5.4 performed best in Accuracy, Safety, and Stage-fit; MiniMax-M2.7 achieved the highest score for Completeness; and Doubao achieved the highest mean score for Understandability. Inter-rater agreement was good [ICC(3,k) = 0.893], and sensitivity analysis supported the primary findings. The three models showed distinct rating profiles in standardized single-turn post-ACLR rehabilitation question answering. Evaluation of patient-facing rehabilitation information should not rely solely on linguistic fluency, but should prioritize medical accuracy, safety, and Stage-fit. These findings provide preliminary benchmark evidence in a phase-sensitive rehabilitation setting, but they should not be interpreted as evidence supporting clinical implementation, clinician substitution, or patient benefit.

  • Open Access

    A Case of Severe Pre‐Eclampsia Complicated by HELLP Syndrome and Extensive Hepatic Infarction

    by Tiange Xia, Fei Gao, Fengming Liang, Yang Shao

    Extensive hepatic infarction is a rare but potentially fatal complication of HELLP syndrome and is often difficult to recognize because of nonspecific clinical manifestations. A 34‐year‐old woman developed HELLP syndrome shortly after cesarean delivery for severe pre‐eclampsia, presenting with oliguria, marked thrombocytopenia (50 × 10 9 /L), and rapidly rising transaminases (ALT 1077 U/L, AST 1280 U/L). Contrast‐enhanced computed tomography (CT) revealed extensive hepatic infarction. Laboratory findings demonstrated microangiopathic hemolysis, severe coagulopathy, and acute kidney injury. Transient elevation of the terminal complement complex C5b‐9 raised concern for atypical hemolytic uremic syndrome. The patient was treated with plasma exchange, corticosteroids, organ support, and individualized anticoagulation guided by bleeding risk assessment. Serial follow‐up demonstrated sustained hematologic, renal, and hepatic recovery, ultimately excluding atypical hemolytic uremic syndrome. This case highlights the importance of imaging‐guided diagnosis, dynamic laboratory evaluation, and individualized therapeutic decision‐making in HELLP syndrome complicated by severe hepatic injury.

  • Open Access

    Single-cell RNA sequencing provides new insights into the interaction between astrocytes and neurons after spinal cord injury in mice

    by Zhi Tang, Hengyang Lu, Xiao Yang, Mao Wu, Junfeng Yang, Shaoshuo Li, Heng Liu, Junkang Zhou, Bin Tang, Xinyao Du, et al.


  • Open Access

    Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury

    by Shaoshuo Li, Yang Shao, Hao Chen, Jianwei Wang

    Objective. To identify the potential pharmacological targets of Jisuikang (JSK) for the treatment of spinal cord injury (SCI) using network pharmacology. Methods. The bioactive compounds of JSK herbs and their corresponding potential SCI targets were obtained from three traditional Chinese medicine (TCM) databases. SCI-related therapeutic target genes were obtained from the Comparative Toxicogenomics Database and the GeneCards Database. The common target genes between the JSK compounds and SCI-related therapeutic targets were screened using GO/KEGG functional enrichment and protein-protein interaction (PPI) analyses to identify hub genes and their categories of biological function. Gene expression distribution and receiver operating characteristic curve (ROC) analyses were used to identify probable SCI-related target genes. Molecular docking was used to quantify molecular interactions between target genes and the bioactive compounds of JSK. Results. A total of 183 JSK bioactive compounds and 197 target genes for the treatment of SCI were screened and assessed. The target genes were enriched primarily in drug metabolism and in inflammation-related biological processes. Ten genes with statistical significance were identified as therapeutic SCI-related target genes of JSK. Molecular docking experiments demonstrated that the proteins of these 10 genes docked with binding energies of less than 5kcal/mol with the bioactive compounds in JSK. Conclusion. This study showed that the anti-SCI effects of JSK may be mediated through numerous bioactive components, multiple gene targets, and inflammation-related pathways and provided potential novel targets for directed therapies for treating SCI. These results provide a foundation for further experimental investigations into treatment options for SCI.


  • Open Access

    p16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma

    by Yang Shao, Hongguo Jiang, Xiaoming Wu, Ying Luo, Wenru Tang

    The present study aimed to investigate the effects of p16 hypermethylation on the risk of nasopharyngeal carcinoma (NPC) quantitatively, through a meta‑analysis of available case‑control studies including malignant and normal NPC tissue samples. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were extracted and pooled to assess the strength of the association between p16 hypermethylation and NPC risk. A total of 9 studies, including 406 NPC and 376 control cases, were identified for meta‑analysis. Statistically significant ORs of p16 hypermethylation were obtained from the NPC and control groups (OR=19.53; 95% CI: 9.54‑39.97; P=0.685). The meta‑analysis indicated that p16 hypermethylation significantly increases NPC risk.